Quy, Pham Nguyen
Fukuyama, Keita
Kanai, Masashi http://orcid.org/0000-0002-6954-4474
Kou, Tadayuki
Kondo, Tomohiro
Yoshioka, Masahiro
Matsubara, Junichi
Sakuma, Tomohiro
Minamiguchi, Sachiko
Matsumoto, Shigemi
Muto, Manabu
Funding for this research was provided by:
japan agency for medical research and development (17kk0205006h0002)
Article History
Received: 15 July 2021
Accepted: 4 April 2022
First Online: 15 April 2022
Declarations
:
: The present study was approved by the Ethics Committee of the Kyoto University Graduate School of Medicine (Kyoto, Japan; G617 and G692). All patients provided written informed consent for the use of genomic and clinical data for research purposes.
: All participants granted consent in written form for the publication of the de-identified results.
: TS is employees at Mitsui Knowledge Industry. MK and SM2 received honoraria from Chugai Pharmaceutical. MM received honoraria from Mistui Knowledge Inc., Sysmex, Riken Genesis, Taiho, SCREEN and Chugai Pharmaceutical. All remaining authors declare no conflicts of interest.